Facts by the World Health Organization
• Chronic diseases and cancer diseases are continuing growing
• Germany – one in four people dying of cancer
• Cancer is the second leading cause of death (behind cardiovascular diseases)
| Year of world Statistics | New Cancer Cases | Deceased individuals |
| 2008 | 12.7 Million | 7.6 Million |
| 2012 | 14.1 Million | 8.2 Million |
Source: WHO 2012
http://www.iarc.fr/en/media-centre/pr/2013/pdfs/pr223_E.pdf
The Facts by Cancer Register NRW
• The more precisely you know the primary tumor, the better you can deal with
• The earlier the cancer is detected, the greater the chances of survival.
| Stage | Average 5 Year Survival Rate In Percentage |
| Stage I | 98 |
| Stage II A | 93 |
| Stage II B | 82 |
| Stage III | 64 |
| Stage IV | 23 |
Source: Epidemiologisches Krebsregister NRW/ DE –Jahr 2000-2004
The Facts
- The health insurance companies have to decrease the treatment costs
- Today the patients are more informed about complex interplays and symptoms via the internet. They arebecoming more impatient and want to have faster and more precise results
- The Doctors always intend to make a very good job but getting more and more under pressure:
- The patient wants to become healthy faster
- The health insurance companies want to reduce their costs
- The medical institutions have to become more economically efficient
The Advantages
- Accuracy of more than 95% without tissue samples ot the tumor
- Preventing of cancer spread – no biopsy
- Simple to handle and relatively cost-effective test
- Fast results within 48 hours
- Innovative Method, not comparable to the current market
- Opportunity of focused and detailed clarification
- Absolute painless examination
- Easy to handle and to use for medical centers,laboratories, clinics and sanatoriums
The Result – detailed PDF report
- accuracy:
- • 50-60% with breast cancer, leukemia and skin cancer (e.g. melanoma, basalioma)
- • 90-95% with all other cancersContaining following data:
- New growth
- Malignant or benign
- Term on ICD-10
- Precise position
- Stage of cancer
- Metastasis
- Accompanying diseases
- Tendency
- Suggestions and time frame for the exact medical clarification
Capabilities of the new way of Cancer Diagnostic:
- Recognizing cancer at its early stage
- Determine tendencies before origin or the detection by MRT
- Localizing point of origin (primary tumor)
- Identify the stage
- Determining its size and possible spread
- Identifying further accompanying diseases
The Methodology
- Definition of cancer via DNA – or saliva sample in the mouth mucosa
- Cytomorphologic examination of the cell parameter and their combinations (cell shape, cell nucleus, electric charge cell nucleus, condition of the membranes etc.)
- Recommended time between the tests: 6 months (if possible different periods, as recommended in each test result)
Analysis
- Smear of the mouth mucosa
- Reading the sample by means of biological microscopes
- Preparing the sample in the SWISS-MEDISCAN system
- Computer based analysis in the SWISS_MEDISCAN Lab during 48h
